The Future of BioPharma blog provides timely coverage of news that directly impacts the business strategies of the biotech, pharmaceutical and medical device industries. In addition to news coverage, the Future of BioPharma blog features live event coverage from IIR's Biopharmaceutical and Healthcare division.
As Senior Vice President and Head of Biopharmaceuticals R&D and Head of Biopharmaceuticals R&D and Worldwide Business Development (WWBD) at GlaxoSmithKline, Dr. Tomlinson combines the resources and development expertise of a large pharmaceutical company, with the entrepreneurial spirit of a smaller biotech organization, bringing early research, late-stage biopharm development and manufacturing expertise into one organization. He served as the Chief Scientific Officer and Executive Vice President of Domantis Inc., and Domantis Limited. Dr. Tomlinson co-founded Domantis Limited in 2000.
In this interview, listen to his views on antibody therapeutic development, shaped by his background both in large pharma and smaller biotech.
Thank you for such a fantastic blog. Where else could anyone get that kind of info written in such a perfect way? I have a presentation that I am presently working on, and I have been on the lookout for such information. latest technologies in computer
1 comment :
Thank you for such a fantastic blog. Where else could anyone get that kind of info written in such a perfect way? I have a presentation that I am presently working on, and I have been on the lookout for such information.
latest technologies in computer
Post a Comment